Issued today, a new report from the American Heart Association (AHA) and the American College of Cardiology (ACC) on medical ethics and professionalism addresses important and timely topics in cardiovascular medicine including ...
May 12, 2021
0
6
Two studies at Sam Houston State University examined issues of sexual orientation and intimate partner violence, including its impact on substance abuse and physical and mental health as well as the effects of child abuse ...
Mar 4, 2014
0
0
An article published in Translational Behavioral Medicine explores the role of behavioral medicine in addressing climate change-related health inequities.
Aug 1, 2022
0
12
The impact of COVID-19 has been felt unevenly across America, with some communities suffering more than others. In Chicago, for example, Black and Latinx residents have accounted for a disproportionate percentage of the known ...
Jan 29, 2021
0
2
Soon, the federal government will allow states to use Medicaid funds to treat prisoners for drug addiction and mental health services.
Feb 22, 2023
0
2
The rate of unmet need for mental health care is significant among Blacks, reducing quality of life and causing disability. Sirry Alang, assistant professor of sociology and health, medicine and society at Lehigh University ...
Feb 5, 2019
0
0
An innovative program that requires alcohol-involved offenders to abstain from alcohol and submit to frequent alcohol tests may be associated with a reduction in deaths, according to a new RAND Corporation study.
Feb 9, 2016
0
1
In her ongoing research about Americans' responses to the COVID-19 pandemic, Northern Arizona University anthropology professor Lisa Hardy and her collaborators have talked to dozens of people. A couple of them stand out ...
Sep 25, 2020
0
1
(Medical Xpress)—The minds of murderers who kill impulsively, often out of rage, and those who carefully carry out premeditated crimes differ markedly both psychologically and intellectually, according to a new study by ...
Jun 27, 2013
1
0
Danish drug maker Novo Nordisk says it has reached a $46.5 million settlement with U.S. authorities over allegations that it hadn't properly communicated safety information when marketing a medicine to treat type 2 diabetes.
Sep 6, 2017
0
0
